SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000886163-15-000097
Filing Date
2015-09-10
Accepted
2015-09-10 16:48:29
Documents
2
Period of Report
2015-09-09
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lgnd_form8-kxbylawsamendme.htm 8-K 27503
2 EXHIBIT 3.1 thirdamendedandrestatedbyl.htm EX-3.1 98748
  Complete submission text file 0000886163-15-000097.txt   127436
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33093 | Film No.: 151101621
SIC: 2834 Pharmaceutical Preparations